Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 17 | 2020 | 143 | 4.100 |
Why?
|
| Cell Differentiation | 13 | 2020 | 427 | 2.180 |
Why?
|
| Immunity, Innate | 5 | 2025 | 231 | 1.810 |
Why?
|
| Interferon Regulatory Factors | 5 | 2020 | 58 | 1.780 |
Why?
|
| Lung | 7 | 2025 | 382 | 1.300 |
Why?
|
| Orthomyxoviridae Infections | 4 | 2025 | 40 | 1.190 |
Why?
|
| Estrogen Receptor alpha | 5 | 2015 | 27 | 1.110 |
Why?
|
| Mice | 30 | 2025 | 4802 | 0.900 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2020 | 59 | 0.890 |
Why?
|
| Lymphocytes | 1 | 2025 | 90 | 0.890 |
Why?
|
| Estrogens | 5 | 2015 | 56 | 0.880 |
Why?
|
| Animals | 36 | 2025 | 10684 | 0.810 |
Why?
|
| Influenza A virus | 2 | 2025 | 37 | 0.810 |
Why?
|
| Lymphocyte Activation | 4 | 2021 | 210 | 0.750 |
Why?
|
| Receptors, Estrogen | 4 | 2012 | 43 | 0.750 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2019 | 60 | 0.710 |
Why?
|
| Mice, Inbred C57BL | 12 | 2025 | 1653 | 0.700 |
Why?
|
| Estrogen Receptor beta | 2 | 2015 | 14 | 0.690 |
Why?
|
| Bone Marrow Cells | 5 | 2009 | 81 | 0.680 |
Why?
|
| Signal Transduction | 9 | 2024 | 1469 | 0.660 |
Why?
|
| Natural Killer T-Cells | 3 | 2016 | 55 | 0.650 |
Why?
|
| Estradiol | 5 | 2009 | 176 | 0.650 |
Why?
|
| Sex Characteristics | 4 | 2025 | 173 | 0.590 |
Why?
|
| Immunologic Memory | 1 | 2019 | 58 | 0.590 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 98 | 0.580 |
Why?
|
| Cells, Cultured | 12 | 2023 | 1022 | 0.550 |
Why?
|
| Inflammation | 4 | 2025 | 667 | 0.520 |
Why?
|
| Macrophages | 6 | 2019 | 305 | 0.510 |
Why?
|
| Inflammation Mediators | 4 | 2017 | 169 | 0.500 |
Why?
|
| West Nile virus | 1 | 2016 | 20 | 0.500 |
Why?
|
| Mice, Knockout | 10 | 2025 | 874 | 0.470 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 38 | 0.440 |
Why?
|
| Female | 19 | 2025 | 15624 | 0.430 |
Why?
|
| Interferon-gamma | 4 | 2025 | 108 | 0.430 |
Why?
|
| Antigen-Presenting Cells | 4 | 2012 | 33 | 0.430 |
Why?
|
| Cytokines | 5 | 2025 | 451 | 0.380 |
Why?
|
| CD11b Antigen | 3 | 2012 | 42 | 0.380 |
Why?
|
| Immune System | 1 | 2012 | 29 | 0.370 |
Why?
|
| Lymph Nodes | 1 | 2012 | 103 | 0.370 |
Why?
|
| Histocompatibility Antigens Class II | 7 | 2009 | 61 | 0.360 |
Why?
|
| Antigen Presentation | 10 | 2009 | 82 | 0.360 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2009 | 19 | 0.360 |
Why?
|
| Homeostasis | 1 | 2012 | 119 | 0.350 |
Why?
|
| Skin | 1 | 2012 | 152 | 0.350 |
Why?
|
| Bacillus anthracis | 2 | 2025 | 153 | 0.350 |
Why?
|
| Antigens, Bacterial | 2 | 2025 | 165 | 0.350 |
Why?
|
| T-Lymphocytes | 6 | 2021 | 285 | 0.350 |
Why?
|
| Phenotype | 3 | 2025 | 685 | 0.340 |
Why?
|
| CD11c Antigen | 2 | 2016 | 10 | 0.330 |
Why?
|
| Cell Movement | 1 | 2012 | 376 | 0.330 |
Why?
|
| Male | 13 | 2025 | 13921 | 0.330 |
Why?
|
| Adipose Tissue | 2 | 2025 | 195 | 0.310 |
Why?
|
| Bacterial Toxins | 2 | 2025 | 273 | 0.310 |
Why?
|
| Autoantigens | 4 | 2007 | 212 | 0.300 |
Why?
|
| Dehydroepiandrosterone | 1 | 2008 | 15 | 0.290 |
Why?
|
| Growth Inhibitors | 2 | 2005 | 11 | 0.290 |
Why?
|
| Lectins, C-Type | 2 | 2025 | 44 | 0.290 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 634 | 0.290 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2008 | 2 | 0.280 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 53 | 0.260 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 1507 | 0.260 |
Why?
|
| RNA, Messenger | 2 | 2025 | 668 | 0.250 |
Why?
|
| Langerhans Cells | 1 | 2005 | 3 | 0.240 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 3 | 2007 | 12 | 0.240 |
Why?
|
| Interferon Type I | 2 | 2017 | 56 | 0.240 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2007 | 134 | 0.240 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2005 | 8 | 0.240 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2005 | 8 | 0.240 |
Why?
|
| Interleukin-5 | 1 | 2025 | 8 | 0.240 |
Why?
|
| Tamoxifen | 1 | 2005 | 34 | 0.230 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2025 | 7 | 0.230 |
Why?
|
| Blood Coagulation Disorders | 1 | 2025 | 28 | 0.230 |
Why?
|
| Gene Transfer Techniques | 1 | 2025 | 74 | 0.230 |
Why?
|
| Receptors, Immunologic | 1 | 2025 | 73 | 0.230 |
Why?
|
| Sepsis | 1 | 2025 | 86 | 0.220 |
Why?
|
| Anthrax | 1 | 2025 | 91 | 0.220 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 46 | 0.220 |
Why?
|
| Humans | 19 | 2025 | 28851 | 0.220 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2009 | 994 | 0.220 |
Why?
|
| Blood Coagulation | 1 | 2025 | 120 | 0.220 |
Why?
|
| Membrane Proteins | 1 | 2008 | 485 | 0.210 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 82 | 0.210 |
Why?
|
| Neutrophils | 3 | 2025 | 183 | 0.210 |
Why?
|
| Endocytosis | 3 | 2025 | 96 | 0.210 |
Why?
|
| Metal Nanoparticles | 1 | 2025 | 137 | 0.210 |
Why?
|
| Sex Factors | 1 | 2025 | 467 | 0.210 |
Why?
|
| Ovary | 1 | 2024 | 72 | 0.200 |
Why?
|
| Drug Delivery Systems | 1 | 2025 | 236 | 0.200 |
Why?
|
| HLA-DR4 Antigen | 1 | 2002 | 2 | 0.200 |
Why?
|
| Communicable Diseases | 1 | 2023 | 20 | 0.200 |
Why?
|
| Endothelium, Vascular | 1 | 2025 | 334 | 0.190 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 92 | 0.180 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 51 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 3 | 2022 | 68 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2022 | 92 | 0.170 |
Why?
|
| Smoke | 1 | 2021 | 37 | 0.170 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2021 | 42 | 0.170 |
Why?
|
| Androgens | 1 | 2020 | 47 | 0.170 |
Why?
|
| Coculture Techniques | 2 | 2019 | 55 | 0.160 |
Why?
|
| Protein Binding | 4 | 2016 | 667 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2009 | 14 | 0.160 |
Why?
|
| Peptides | 2 | 2022 | 296 | 0.160 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2009 | 35 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2023 | 523 | 0.150 |
Why?
|
| Lymphocyte Count | 1 | 2019 | 15 | 0.150 |
Why?
|
| Autoimmunity | 1 | 2020 | 158 | 0.150 |
Why?
|
| Flow Cytometry | 3 | 2016 | 292 | 0.150 |
Why?
|
| Phagocytosis | 1 | 2019 | 80 | 0.140 |
Why?
|
| H-2 Antigens | 1 | 1998 | 14 | 0.140 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2017 | 9 | 0.130 |
Why?
|
| Tobacco Products | 1 | 2021 | 205 | 0.130 |
Why?
|
| Spleen | 2 | 2020 | 113 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2017 | 56 | 0.130 |
Why?
|
| Cell Line, Tumor | 5 | 2025 | 1350 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2017 | 26 | 0.130 |
Why?
|
| Allergy and Immunology | 1 | 2016 | 5 | 0.130 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2016 | 3 | 0.130 |
Why?
|
| Women | 1 | 2016 | 12 | 0.130 |
Why?
|
| Education, Graduate | 1 | 2016 | 9 | 0.130 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2016 | 12 | 0.130 |
Why?
|
| Macrophages, Alveolar | 1 | 2016 | 36 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2016 | 15 | 0.130 |
Why?
|
| Academies and Institutes | 1 | 2016 | 16 | 0.130 |
Why?
|
| Genome, Viral | 1 | 2016 | 34 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2016 | 61 | 0.130 |
Why?
|
| Virus Replication | 1 | 2016 | 66 | 0.120 |
Why?
|
| Faculty | 1 | 2016 | 62 | 0.120 |
Why?
|
| Synovial Membrane | 2 | 2025 | 13 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2016 | 84 | 0.120 |
Why?
|
| Lipopolysaccharides | 3 | 2023 | 157 | 0.120 |
Why?
|
| RNA, Viral | 1 | 2016 | 68 | 0.120 |
Why?
|
| Aging | 1 | 2024 | 1016 | 0.120 |
Why?
|
| Universities | 1 | 2016 | 124 | 0.120 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 513 | 0.120 |
Why?
|
| Culture Media, Conditioned | 2 | 2005 | 31 | 0.110 |
Why?
|
| Sjogren's Syndrome | 1 | 2017 | 274 | 0.100 |
Why?
|
| B-Lymphocytes | 3 | 2009 | 285 | 0.100 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2009 | 12 | 0.100 |
Why?
|
| Biomarkers | 1 | 2016 | 776 | 0.100 |
Why?
|
| Dynamins | 2 | 2009 | 8 | 0.100 |
Why?
|
| Antigens, Surface | 2 | 2019 | 39 | 0.100 |
Why?
|
| Antigens, CD1d | 1 | 2012 | 45 | 0.090 |
Why?
|
| Cell Count | 2 | 2009 | 86 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 676 | 0.090 |
Why?
|
| Immune Tolerance | 3 | 2009 | 52 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 699 | 0.090 |
Why?
|
| Retroviridae | 1 | 2009 | 16 | 0.080 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2009 | 7 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 28 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 58 | 0.080 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2009 | 31 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2009 | 27 | 0.080 |
Why?
|
| Neuropeptides | 1 | 2009 | 27 | 0.080 |
Why?
|
| Pregnancy | 1 | 2014 | 1254 | 0.080 |
Why?
|
| Hybridomas | 3 | 2007 | 17 | 0.080 |
Why?
|
| Glycoproteins | 2 | 2016 | 124 | 0.080 |
Why?
|
| Encephalitis | 1 | 2008 | 18 | 0.070 |
Why?
|
| Herpesvirus 1, Human | 1 | 2008 | 24 | 0.070 |
Why?
|
| Brain Stem | 1 | 2008 | 23 | 0.070 |
Why?
|
| Herpes Simplex | 1 | 2008 | 20 | 0.070 |
Why?
|
| Ligands | 1 | 2008 | 178 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2007 | 13 | 0.070 |
Why?
|
| Collagen Type II | 2 | 2007 | 12 | 0.070 |
Why?
|
| Stem Cells | 1 | 2008 | 123 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2022 | 278 | 0.060 |
Why?
|
| Mannose-Binding Lectins | 1 | 2005 | 4 | 0.060 |
Why?
|
| Complement Activation | 1 | 2025 | 27 | 0.060 |
Why?
|
| Papio | 1 | 2025 | 81 | 0.060 |
Why?
|
| Endosomes | 1 | 2025 | 53 | 0.060 |
Why?
|
| Cell Line | 2 | 2005 | 700 | 0.060 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2025 | 40 | 0.060 |
Why?
|
| Synovial Fluid | 1 | 2025 | 12 | 0.060 |
Why?
|
| Time Factors | 2 | 2021 | 1613 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2005 | 72 | 0.060 |
Why?
|
| Gold | 1 | 2025 | 137 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 150 | 0.050 |
Why?
|
| Interphase | 1 | 2004 | 6 | 0.050 |
Why?
|
| Estrogen Antagonists | 1 | 2004 | 16 | 0.050 |
Why?
|
| Oocytes | 1 | 2024 | 24 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2004 | 26 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 154 | 0.050 |
Why?
|
| Proteomics | 1 | 2025 | 197 | 0.050 |
Why?
|
| Fertility | 1 | 2024 | 60 | 0.050 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2023 | 11 | 0.050 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Lectins | 1 | 2002 | 13 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2002 | 13 | 0.050 |
Why?
|
| Adipokines | 1 | 2002 | 9 | 0.050 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2023 | 65 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 242 | 0.050 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2022 | 9 | 0.050 |
Why?
|
| Alleles | 2 | 2017 | 354 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 251 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 80 | 0.050 |
Why?
|
| Mutation | 2 | 2020 | 867 | 0.050 |
Why?
|
| Adult | 2 | 2016 | 8024 | 0.040 |
Why?
|
| Cytosol | 1 | 2001 | 49 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2001 | 72 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 82 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 247 | 0.040 |
Why?
|
| Receptors, Vitronectin | 1 | 2019 | 4 | 0.040 |
Why?
|
| Protein S | 1 | 2019 | 26 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2019 | 23 | 0.040 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2019 | 13 | 0.040 |
Why?
|
| Milk Proteins | 1 | 2019 | 19 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2019 | 22 | 0.040 |
Why?
|
| Transcriptome | 1 | 2020 | 231 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2019 | 63 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2019 | 96 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2019 | 74 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1998 | 53 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 612 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 24 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2017 | 17 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 48 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2017 | 46 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2017 | 39 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 115 | 0.030 |
Why?
|
| Knee Joint | 1 | 2017 | 43 | 0.030 |
Why?
|
| B7-2 Antigen | 1 | 2016 | 8 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2016 | 14 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1998 | 112 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2016 | 34 | 0.030 |
Why?
|
| Antigens, CD1 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Leptin | 1 | 2017 | 67 | 0.030 |
Why?
|
| Adipocytes | 1 | 2017 | 59 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 142 | 0.030 |
Why?
|
| HLA-D Antigens | 1 | 1996 | 6 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 140 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 144 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 149 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 465 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 284 | 0.030 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2013 | 7 | 0.030 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2013 | 2 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 9 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 2013 | 8 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 9 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 841 | 0.020 |
Why?
|
| Immunization | 1 | 2012 | 121 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2012 | 83 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 257 | 0.020 |
Why?
|
| United States | 1 | 2016 | 2222 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 515 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 824 | 0.020 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2009 | 11 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mice, Inbred NZB | 1 | 2009 | 14 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2009 | 21 | 0.020 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2009 | 3 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 11 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2009 | 50 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 119 | 0.020 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2008 | 1 | 0.020 |
Why?
|
| Virus Shedding | 1 | 2008 | 3 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 5 | 0.020 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Acyclovir | 1 | 2008 | 8 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 585 | 0.020 |
Why?
|
| Eye | 1 | 2008 | 36 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 49 | 0.020 |
Why?
|
| Half-Life | 1 | 2007 | 34 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 288 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2007 | 18 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 697 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2008 | 114 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 1056 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 5598 | 0.020 |
Why?
|
| Epitopes | 1 | 2007 | 185 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2009 | 481 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2007 | 160 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2007 | 452 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2007 | 268 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 7414 | 0.010 |
Why?
|
| Automation | 1 | 2001 | 21 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2001 | 54 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2001 | 131 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2001 | 265 | 0.010 |
Why?
|
| Proteins | 1 | 2001 | 254 | 0.010 |
Why?
|
| Algorithms | 1 | 2001 | 431 | 0.010 |
Why?
|
| HLA-DR5 Antigen | 1 | 1996 | 1 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 258 | 0.010 |
Why?
|
| Transfection | 1 | 1996 | 319 | 0.010 |
Why?
|